CYTORA awarded 10th Grant by the Israel Innovation Authority

CYTORA a pioneering biopharma company advancing next-generation stem cell therapies, are proud to share that we have been awarded our 10th Grant from the Israel Innovation Authority.

​

Since our founding in 2018, The Israel Innovation Authority has supported CYTORA at every milestone – providing non-dilutive funding from our early incubator days, through POC, Seed, R&D, to our ongoing clinical trials and now our transition to full scale production.

​

We extend our sincere gratitude to the Israel Innovation Authority for being a trusted partner on our journey and working toward our mission of addressing some of the most challenging medical conditions of the decade.